XML 69 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Preferred and Common Stock Warrants (Tables)
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Schedule of Outstanding Warrants
The following table provides a roll forward of outstanding warrants for the nine month period ended September 30, 2019:
Number of
warrants
Weighted
Average
Exercise
Price
Weighted
Average
Contractual
Term (Years)
Outstanding and exercisable warrants to purchase preferred shares as of December 31, 20185,146,400  $—  4.23
Conversion of warrant to purchase preferred shares to warrants for the purchase of common stock and adjusted for the Exchange Ratio and Reverse Stock Split
(4,657,350) 
Issuance of warrants for the purchase of common stock6,035,000  12.43  
Exercised(33,846) 13.20  
Cancelled—  —  
Outstanding and exercisable as of September 30, 20196,490,204  $13.03  2.98
Schedule of Warrant to Purchase Redeemable Convertible Preferred Stock
As of September 30, 2019, the Company’s outstanding warrants to purchase shares of common stock consisted of the following:
Issuance DateNumber of
Shares of
Common
Stock Issuable
Exercise
Price
ClassificationExpiration Date
August 14, 201581,228  $21.78  EquityAugust 14, 2020
August 21, 201569,603  $21.78  EquityAugust 21, 2020
October 25, 20165,155  $19.78  EquityOctober 24, 2026
November 1, 2017130,609  $19.78  EquityOctober 31, 2020
November 17, 20178,442  $19.78  EquityNovember 16, 2020
December 4, 20175,661  $19.78  EquityDecember 3, 2020
December 28, 20176,925  $19.78  EquityDecember 27, 2020
December 28, 2017115,916  $19.78  EquityDecember 28, 2027
September 12, 201825,275  $19.78  EquitySeptember 12, 2021
September 12, 201820,220  $19.78  EquitySeptember 12, 2028
October 19, 201820,016  $19.78  EquityOctober 19, 2028
March 13, 20195,000  $19.80  EquityMarch 12, 2029
April 16, 20193,866,154  $13.20  EquityApril 15, 2024
April 16, 20192,130,000  $11.00  Equityn/a
6,490,204  
 
As of December 31, 2018, the Company’s outstanding warrants to purchase shares of preferred stock (which converted into warrants to purchase common stock upon close of the Merger) consisted of the following (not adjusted for the Reverse Stock Split or Exchange Ratio):
December 31, 2018
Warrant NameIssuance DateNumber of
Shares of
Preferred
Stock Issuable
Exercise
Price
Exercisable
for
ClassificationExpiration Date
Series A warrantsAugust 14, 2015854,785  $2.07  Series ALiabilityAugust 14, 2020
Series A warrantsAugust 21, 2015732,453  $2.07  Series ALiabilityAugust 21, 2020
SVB warrantsOctober 25, 201654,256  $1.88  Series ALiabilityOctober 24, 2026
Series B warrantsNovember 1, 20171,374,435  $1.88  Series BLiabilityOctober 31, 2020
Series B warrantsNovember 17, 201788,845  $1.88  Series BLiabilityNovember 16, 2020
Series B warrantsDecember 4, 201759,576  $1.88  Series BLiabilityDecember 3, 2020
Series B warrantsDecember 28, 201772,875  $1.88  Series BLiabilityDecember 27, 2020
Series B warrantsDecember 28, 20171,219,815  $1.88  Series BLiabilityDecember 28, 2027
Series B warrantsSeptember 12, 2018265,957  $1.88  Series BLiabilitySeptember 12, 2021
Series B warrantsSeptember 12, 2018212,765  $1.88  Series BLiabilitySeptember 12, 2028
Series B warrantsOctober 19, 2018210,638  $1.88  Series BLiabilityOctober 19, 2028
5,146,400